Objectives: To describe prevalence rates of bowel, bladder, and sudomotor symptoms in patients with amyotrophic lateral sclerosis (ALS) in relation to disease onset and progression. Treatment strategies and efficacies were also assessed.
Methods: A pilot patient cohort revealed increased incidences of bowel/bladder and sudomotor symptoms.